The global pacemakers market, valued at USD 4.4 billion in 2020, is anticipated to grow to USD 5.4 billion by 2027, at a CAGR of 3.0% during the forecast period (2021-2027). This growth is primarily ...

Fourth quarter revenue up 16% year-over-year, $26.9M of secured debt eliminated, and total cash and escrowed proceeds of $44.3M at year-end GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Elutia ...

The draw: a conference called “Mass Torts Made Perfect,” held in the hotel’s grand ballroom, tucked well behind its famous ...

The world feels ordinary until a single detail shifts your perspective. A quiet fact can linger in your thoughts, reshaping ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

A Boston Scientific (NYSE:BSX) official today took to social media to share news of the first peripheral cases using its ...

Boston Scientific (NYSE: BSX) announced that it received CE mark approval for its Embold detachable coil system.

Boston Scientific Corp.'s Farapoint, its latest pulsed field ablation catheter, received U.S. FDA approval for use as an ...

Boston Scientific is planning a new 300,000-square-foot lab and office building in Maple Grove, expanding its Arbor Lakes ...

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

Executives from the Marlborough, MA-based company discussed its position in the fast-growing pulsed-field ablation market.

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...